Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Lakewood, California 90712


Purpose:

Evaluate the additive role of zileuton 600mg qid to clinically stable asthmatics on Advair 250/50 bid. Since asthma is an endogenous inflammatory disease there usually is increased total exhaled, bronchial and alveolar nitric oxide which are markers of eosinophilic driven pathways of inflammation. The addition of zileuton which is a leukotriene synthesis inhibitor by itself or together with inhaled corticosteroids should reduce nitric oxide gas exchange.


Criteria:

Inclusion Criteria: - Non-smoking - Moderate to severe persistent asthmatics - Clinically stable X 6 weeks on Advair 250/50 bid for at least 12 months Exclusion Criteria: - No leukotriene synthesis inhibitors or receptor antagonists for 6 weeks


NCT ID:

NCT00575861


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Lakewood, California 90712
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.